1. Developing targeted antioxidant nanomedicines for ischemic penumbra: Novel strategies in treating brain ischemia-reperfusion injury.
- Author
-
Hou Z and Brenner JS
- Subjects
- Humans, Animals, Neuroprotective Agents therapeutic use, Neuroprotective Agents pharmacology, Neuroprotective Agents administration & dosage, Reperfusion Injury drug therapy, Reperfusion Injury metabolism, Antioxidants pharmacology, Antioxidants therapeutic use, Antioxidants administration & dosage, Nanomedicine methods, Brain Ischemia drug therapy, Brain Ischemia metabolism, Brain Ischemia pathology, Oxidative Stress drug effects, Reactive Oxygen Species metabolism
- Abstract
During cerebral ischemia-reperfusion conditions, the excessive reactive oxygen species in the ischemic penumbra region, resulting in neuronal oxidative stress, constitute the main pathological mechanism behind ischemia-reperfusion damage. Swiftly reinstating blood perfusion in the ischemic penumbra zone and suppressing neuronal oxidative injury are key to effective treatment. Presently, antioxidants in clinical use suffer from low bioavailability, a singular mechanism of action, and substantial side effects, severely restricting their therapeutic impact and widespread clinical usage. Recently, nanomedicines, owing to their controllable size and shape and surface modifiability, have demonstrated good application potential in biomedicine, potentially breaking through the bottleneck in developing neuroprotective drugs for ischemic strokes. This manuscript intends to clarify the mechanisms of cerebral ischemia-reperfusion injury and provides a comprehensive review of the design and synthesis of antioxidant nanomedicines, their action mechanisms and applications in reversing neuronal oxidative damage, thus presenting novel approaches for ischemic stroke prevention and treatment., Competing Interests: Declaration of competing interest All authors of this research group have no conflicts of interest related to the publication of this article to declare., (Copyright © 2024. Published by Elsevier B.V.)
- Published
- 2024
- Full Text
- View/download PDF